These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


242 related items for PubMed ID: 9504391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
    Lavreysen H, Langlois X, Ahnaou A, Drinkenburg W, te Riele P, Biesmans I, Van der Linden I, Peeters L, Megens A, Wintmolders C, Cid JM, Trabanco AA, Andrés JI, Dautzenberg FM, Lütjens R, Macdonald G, Atack JR.
    J Pharmacol Exp Ther; 2013 Sep; 346(3):514-27. PubMed ID: 23766542
    [Abstract] [Full Text] [Related]

  • 3. Characterization of (2S,2'R,3'R)-2-(2',3'-[3H]-dicarboxycyclopropyl)glycine binding in rat brain.
    Mutel V, Adam G, Chaboz S, Kemp JA, Klingelschmidt A, Messer J, Wichmann J, Woltering T, Richards JG.
    J Neurochem; 1998 Dec; 71(6):2558-64. PubMed ID: 9832156
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y, Kinoshita M, Toyoshima R.
    Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.
    Schaffhauser H, Rowe BA, Morales S, Chavez-Noriega LE, Yin R, Jachec C, Rao SP, Bain G, Pinkerton AB, Vernier JM, Bristow LJ, Varney MA, Daggett LP.
    Mol Pharmacol; 2003 Oct; 64(4):798-810. PubMed ID: 14500736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activator protein-1 responsive to the group II metabotropic glutamate receptor subtype in association with intracellular calcium in cultured rat cortical neurons.
    Sugiyama C, Nakamichi N, Ogura M, Honda E, Maeda S, Taniura H, Yoneda Y.
    Neurochem Int; 2007 Dec; 51(8):467-75. PubMed ID: 17559977
    [Abstract] [Full Text] [Related]

  • 11. Activation of group II mGlu receptors inhibits voltage-gated Ca2+ currents in myenteric neurons.
    Chen WP, Kirchgessner AL.
    Am J Physiol Gastrointest Liver Physiol; 2002 Dec; 283(6):G1282-9. PubMed ID: 12388194
    [Abstract] [Full Text] [Related]

  • 12. Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain.
    Shave E, Pliss L, Lawrance ML, FitzGibbon T, Stastny F, Balcar VJ.
    Neurochem Int; 2001 Jan; 38(1):53-62. PubMed ID: 10913688
    [Abstract] [Full Text] [Related]

  • 13. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    Thomsen C, Bruno V, Nicoletti F, Marinozzi M, Pellicciari R.
    Mol Pharmacol; 1996 Jul; 50(1):6-9. PubMed ID: 8700119
    [Abstract] [Full Text] [Related]

  • 14. Neurotoxicity of (2S,1'R,2'R,3'R)-2-(2,3-dicarboxycyclopropyl)glycine, a potent agonist for class II metabotropic glutamate receptors, in the rat.
    Kwak S, Miyamoto M, Ishida M, Shinozaki H.
    Neuroscience; 1996 Aug; 73(3):687-95. PubMed ID: 8809790
    [Abstract] [Full Text] [Related]

  • 15. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.
    Kirschstein T, von der Brelie C, Steinhäuser M, Vinçon A, Beck H, Dietrich D.
    Neuropharmacology; 2004 Aug; 47(2):157-62. PubMed ID: 15223294
    [Abstract] [Full Text] [Related]

  • 16. (2S,1'S,2'R,3'R)-2(2'-Carboxy-3'-hydroxymethylcyclopropyl)glycine-[3H], a potent and selective radioligand for labeling group 2 and 3 metabotropic glutamate receptors.
    Wheeler WJ, Clodfelter DK, Collado I, Kulanthaivel P, Pedregal C, Stoddard EA, Wright RA, Schoepp DD.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):349-51. PubMed ID: 15603952
    [Abstract] [Full Text] [Related]

  • 17. Metabotropic glutamate and dopamine receptors co-regulate AMPA receptor activity through PKA in cultured chick retinal neurones: effect on GluR4 phosphorylation and surface expression.
    Gomes AR, Cunha P, Nuriya M, Faro CJ, Huganir RL, Pires EV, Carvalho AL, Duarte CB.
    J Neurochem; 2004 Aug 17; 90(3):673-82. PubMed ID: 15255946
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ.
    J Pharmacol Exp Ther; 1999 Jun 17; 289(3):1678-87. PubMed ID: 10336568
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective effects of group II metabotropic glutamate receptor agonist DCG-IV on hippocampal neurons in transient forebrain ischemia.
    Yoshioka H, Sugita M, Kinouchi H.
    Neurosci Lett; 2009 Sep 25; 461(3):266-70. PubMed ID: 19549561
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.